As a next step on Novonesis’ integration journey, we combine the two EVP areas Human Health Biosolutions and Strategy & Integration. COPENHAGEN, Denmark – After successfully combining into one company ...

Lars Rebien Sorensen becomes CEO after serving as the head of Novo's healthcare business. The company's enzymes business was ...

Microbial Source: The most widely used due to cost-effectiveness, scalability, and broad substrate specificity. Microbial lipases, derived from fungi and bacteria, dominate Vietnam’s market, ...

Novonesis, a world-leading biosolutions company, co-hosted its 'Unlocking Value for a Sustainable Future' Partnering Day 2025 ...

Novozymes (NVZMY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

The global leader in biosolutions, Novonesis, had a strong start to its financial year with organic sales growth of 11% and an adjusted EBITDA margin of 38.3%. The company ...

Monsanto, the world’s largest seed company, said Tuesday a deal with Danish company Novozymes to form a long-term research and development alliance should accelerate the release of microbial-based ...

Companies must weigh the risks and benefits of using a holding company to manage their intellectual property (IP) portfolio, ...

Novonesis formed in January 2024, a merger of Novozymes and Chr Hansen. The company offers a portfolio of biological solutions designed to help producers enhance productivity, yields and profitability ...

Biology and technology are accelerating the green transition. The merger of Novozymes and Chr. Hansen has created Novonesis, a global leader in what the new company calls “biosolutions.” ...

Danish enzyme firm Novozymes has completed its $25.6 million cash deal to buy a controlling stake in Saskatoon inoculant maker Philom Bios. The deal gives Philom Bios access to Novozymes’ resources ...